Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

885
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
885
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

1.5K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.5K
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

565
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
565
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

1.0K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.0K
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

500
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
500

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Targeted next-generation sequencing implementation in Eswatini identifies rifampicin and bedaquiline resistance undetected by routine diagnostic testing.

Nature communications·2026
Same author

Diagnostic accuracy study of the multiplex Truenat MTB Ultima/COVID-19 assay for simultaneous detection of Tuberculosis and SARS-CoV2 (COVID-19).

PLOS global public health·2026
Same author

Expanding Xpert MTB/RIF Ultra and lateral flow urine lipoarabinomannan testing for diagnosis of tuberculosis among adults living with HIV admitted to hospitals in Tanzania and Mozambique (EXULTANT): a randomised controlled trial.

The Lancet. Infectious diseases·2026
Same author

Responding Appropriately to Safety Signals in Infants Exposed to the 6-month BDLLfx/BDLCfz Regimen In Utero.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same author

The looming crisis of bedaquiline-resistant tuberculosis and a promising way forward.

The Lancet. Infectious diseases·2026
Same author

A cardiovascular, craniofacial, and neurodevelopmental disorder caused by loss-of-function variants in the eIF3 complex component genes EIF3A and EIF3B.

American journal of human genetics·2026

Video Experimental Relacionado

Updated: Jan 27, 2026

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K

La tuberculosis

Jennifer Furin1, Helen Cox2, Madhukar Pai3

  • 1Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.

Lancet (London, England)
|March 25, 2019
PubMed
Resumen
Este resumen es generado por máquina.

El diagnóstico y el tratamiento de la tuberculosis están avanzando con nuevas pruebas moleculares, terapias totalmente orales para los casos resistentes a los medicamentos y regímenes de prevención más cortos. La mejora del acceso a la atención y la voluntad política son cruciales para combatir esta enfermedad infecciosa.

Más Videos Relacionados

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.2K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K

Videos de Experimentos Relacionados

Last Updated: Jan 27, 2026

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.8K
An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei
09:02

An Experimental Model to Study Tuberculosis-Malaria Coinfection upon Natural Transmission of Mycobacterium tuberculosis and Plasmodium berghei

Published on: February 17, 2014

20.2K
The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis
23:06

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

19.6K

Área de la Ciencia:

  • Salud global
  • Enfermedades infecciosas
  • Diagnóstico médico

Sus antecedentes:

  • La tuberculosis (TB) es una de las principales causas infecciosas de muerte en todo el mundo, que afecta a más de 10 millones de personas al año.
  • Los avances limitados en el tratamiento de la tuberculosis han persistido a pesar de su importante carga para la salud pública.

Objetivo del estudio:

  • Revisar los avances recientes en el diagnóstico y tratamiento de la tuberculosis.
  • Resaltar la necesidad de una atención integrada y centrada en las personas junto con nuevas herramientas.

Principales métodos:

  • Revisión de las innovaciones de diagnóstico, incluidas las pruebas moleculares rápidas y la secuenciación de todo el genoma.
  • Análisis de las directrices de tratamiento actualizadas para la tuberculosis resistente a los medicamentos y la prevención de la tuberculosis latente.
  • Consideración del desarrollo de vacunas para la prevención de la tuberculosis.

Principales resultados:

  • Las nuevas herramientas de diagnóstico ofrecen posibilidades de detección temprana y más precisa de la tuberculosis.
  • La OMS recomienda ahora un tratamiento exclusivamente oral para la tuberculosis resistente a los medicamentos, lo que marca un cambio en el tratamiento.
  • Están surgiendo regímenes más cortos y efectivos para la prevención de la tuberculosis latente y un candidato a vacuna prometedor.

Conclusiones:

  • Los avances en el diagnóstico, la terapia y la prevención ofrecen la esperanza de controlar la tuberculosis.
  • La atención de alta calidad y centrada en el paciente y el renovado compromiso político son esenciales para la erradicación de la tuberculosis.